OBJECT: Obsessive compulsive disorder (OCD) is the fourth most common psychiatric disorder characterized by recurrent, intrusive thoughts and repetitive, ritualistic behaviors that are debilitating to the patient. Despite its high prevalence and the attendant morbidity, the pathophysiology of OCD remains unclear. Magnetic resonance spectroscopy (MRS) provides a noninvasive method to characterize the molecular biochemistry that may contribute to the pathophysiology of OCD. This study aimed to identify alterations in neurochemical measures that are specific to OCD using in vivo proton ((1)H) MRS of the caudate nucleus, anterior cingulate cortex, and medial thalamus in these patients, and to identify their role as vulnerability markers by comparing them with the healthy first degree relatives of these patients and healthy controls. MATERIALS AND METHODS: Appropriate psychometric instruments were applied in the study population followed by (1)H- MRS. The absolute neurochemical measures were quantified using a linear combination model. RESULTS: Significant differences in neurochemical measures were demonstrated in two of the three candidate regions (except the medial thalamus) between the three study groups. CONCLUSIONS: Our results lend support to the neurodegenerative hypothesis of OCD, and also raise the possibility of exploring these neurochemical measures (as measured by MRS) as putative vulnerability biomarkers in OCD that may aid in early identification and devising early prevention or management strategies for the population vulnerable to OCD.
OBJECT: Obsessive compulsive disorder (OCD) is the fourth most common psychiatric disorder characterized by recurrent, intrusive thoughts and repetitive, ritualistic behaviors that are debilitating to the patient. Despite its high prevalence and the attendant morbidity, the pathophysiology of OCD remains unclear. Magnetic resonance spectroscopy (MRS) provides a noninvasive method to characterize the molecular biochemistry that may contribute to the pathophysiology of OCD. This study aimed to identify alterations in neurochemical measures that are specific to OCD using in vivo proton ((1)H) MRS of the caudate nucleus, anterior cingulate cortex, and medial thalamus in these patients, and to identify their role as vulnerability markers by comparing them with the healthy first degree relatives of these patients and healthy controls. MATERIALS AND METHODS: Appropriate psychometric instruments were applied in the study population followed by (1)H- MRS. The absolute neurochemical measures were quantified using a linear combination model. RESULTS: Significant differences in neurochemical measures were demonstrated in two of the three candidate regions (except the medial thalamus) between the three study groups. CONCLUSIONS: Our results lend support to the neurodegenerative hypothesis of OCD, and also raise the possibility of exploring these neurochemical measures (as measured by MRS) as putative vulnerability biomarkers in OCD that may aid in early identification and devising early prevention or management strategies for the population vulnerable to OCD.
Authors: G Nestadt; J Samuels; M Riddle; O J Bienvenu; K Y Liang; M LaBuda; J Walkup; M Grados; R Hoehn-Saric Journal: Arch Gen Psychiatry Date: 2000-04
Authors: Stella J de Wit; Froukje E de Vries; Ysbrand D van der Werf; Danielle C Cath; Dirk J Heslenfeld; Eveline M Veltman; Anton J L M van Balkom; Dick J Veltman; Odile A van den Heuvel Journal: Am J Psychiatry Date: 2012-10 Impact factor: 18.112
Authors: Anouk den Braber; Dennis van 't Ent; Gabriëlla A M Blokland; Daniël S van Grootheest; Danielle C Cath; Dick J Veltman; Michiel B de Ruiter; Dorret I Boomsma Journal: Biol Psychol Date: 2008-02-02 Impact factor: 3.251
Authors: Murat Yücel; Stephen J Wood; R Mark Wellard; Ben J Harrison; Alex Fornito; Jesus Pujol; Dennis Velakoulis; Christos Pantelis Journal: Aust N Z J Psychiatry Date: 2008-06 Impact factor: 5.744
Authors: Andrew R Gilbert; Matcheri S Keshavan; Vaibhav Diwadkar; Jeffrey Nutche; Frank Macmaster; Phillip C Easter; Christian J Buhagiar; David R Rosenberg Journal: Neurosci Lett Date: 2008-02-12 Impact factor: 3.046
Authors: Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch Journal: Neuropsychopharmacology Date: 2015-02-09 Impact factor: 7.853
Authors: Jilly Naaijen; Marcel P Zwiers; Houshang Amiri; Steven C R Williams; Sarah Durston; Bob Oranje; Daniel Brandeis; Regina Boecker-Schlier; Matthias Ruf; Isabella Wolf; Tobias Banaschewski; Jeffrey C Glennon; Barbara Franke; Jan K Buitelaar; David J Lythgoe Journal: Neuropsychopharmacology Date: 2016-11-21 Impact factor: 7.853
Authors: Jilly Naaijen; Natalie J Forde; David J Lythgoe; Sophie E A Akkermans; Thaira J C Openneer; Andrea Dietrich; Marcel P Zwiers; Pieter J Hoekstra; Jan K Buitelaar Journal: Neuroimage Clin Date: 2016-11-16 Impact factor: 4.881